Local therapy treatment conditions for oligometastatic non-small cell lung cancer

HIGHLIGHTS

• who: Suli Zhang from the (BARC), India University of Florence, Italy have published the research work: Local therapy treatment conditions for oligometastatic non-small cell lung cancer, in the Journal: (JOURNAL)
• what: PFS and OS benefit have been shown after ablation therapy for OM-NSCLC.
• how: The data showed that PFS was significantly improved in the LCT group with PFS of 11.9 months and 3.9 months in study and control groups respectively after a median follow-up of 12 months (P=0.0054). The results showed that SABR was associated with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.